[go: up one dir, main page]

IL136025A0 - Combination therapy for the treatment of migraine - Google Patents

Combination therapy for the treatment of migraine

Info

Publication number
IL136025A0
IL136025A0 IL13602500A IL13602500A IL136025A0 IL 136025 A0 IL136025 A0 IL 136025A0 IL 13602500 A IL13602500 A IL 13602500A IL 13602500 A IL13602500 A IL 13602500A IL 136025 A0 IL136025 A0 IL 136025A0
Authority
IL
Israel
Prior art keywords
migraine
treatment
combination therapy
therapy
combination
Prior art date
Application number
IL13602500A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL136025A0 publication Critical patent/IL136025A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL13602500A 1999-05-14 2000-05-08 Combination therapy for the treatment of migraine IL136025A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13431299P 1999-05-14 1999-05-14

Publications (1)

Publication Number Publication Date
IL136025A0 true IL136025A0 (en) 2001-05-20

Family

ID=22462780

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13602500A IL136025A0 (en) 1999-05-14 2000-05-08 Combination therapy for the treatment of migraine

Country Status (11)

Country Link
US (1) US20050101653A1 (fr)
EP (1) EP1051995A3 (fr)
JP (1) JP2000344667A (fr)
KR (1) KR20010029716A (fr)
AU (1) AU3406500A (fr)
CA (1) CA2308826A1 (fr)
CO (1) CO5261541A1 (fr)
HU (1) HUP0001891A3 (fr)
IL (1) IL136025A0 (fr)
PE (1) PE20010128A1 (fr)
ZA (1) ZA200002338B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8022095B2 (en) 1996-08-16 2011-09-20 Pozen, Inc. Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
WO2000025779A1 (fr) 1998-11-02 2000-05-11 Merck & Co., Inc. Methode de traitement des migraines et compositions pharmaceutiques associees
GB9929039D0 (en) * 1999-12-08 2000-02-02 Glaxo Group Ltd Medicaments
EP1575566B1 (fr) 2002-12-26 2012-02-22 Pozen, Inc. Formes galeniques multicouches contenant de naproxene et des triptanes
CA2521902A1 (fr) * 2003-04-11 2004-10-21 Pfizer Inc. Combinaison pharmaceutique a base d'eletriptan et de bicarbonate de sodium
US8618157B2 (en) 2008-06-20 2013-12-31 Alphapharm Pty. Ltd. Pharmaceutical formulation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5286843A (en) * 1992-05-22 1994-02-15 Rohm And Haas Company Process for improving water-whitening resistance of pressure sensitive adhesives
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
RO118291B1 (ro) * 1993-11-30 2003-04-30 Searle & Co Derivati de pirazol 1,3,4,5 - tetrasubstituiti si compozitie farmaceutica care ii contine
US5691374A (en) * 1995-05-18 1997-11-25 Merck Frosst Canada Inc. Diaryl-5-oxygenated-2-(5H) -furanones as COX-2 inhibitors
US5861419A (en) * 1996-07-18 1999-01-19 Merck Frosst Canad, Inc. Substituted pyridines as selective cyclooxygenase-2 inhibitors
US5872145A (en) * 1996-08-16 1999-02-16 Pozen, Inc. Formulation of 5-HT agonist and NSAID for treatment of migraine
US6034256A (en) * 1997-04-21 2000-03-07 G.D. Searle & Co. Substituted benzopyran derivatives for the treatment of inflammation
US6077850A (en) * 1997-04-21 2000-06-20 G.D. Searle & Co. Substituted benzopyran analogs for the treatment of inflammation
US5994379A (en) * 1998-02-13 1999-11-30 Merck Frosst Canada, Inc. Bisaryl COX-2 inhibiting compounds, compositions and methods of use

Also Published As

Publication number Publication date
AU3406500A (en) 2000-11-16
US20050101653A1 (en) 2005-05-12
HUP0001891A2 (en) 2001-03-28
KR20010029716A (ko) 2001-04-16
CO5261541A1 (es) 2003-03-31
HUP0001891A3 (en) 2003-07-28
CA2308826A1 (fr) 2000-11-14
EP1051995A3 (fr) 2003-01-08
JP2000344667A (ja) 2000-12-12
PE20010128A1 (es) 2001-02-28
HU0001891D0 (en) 2000-07-28
EP1051995A2 (fr) 2000-11-15
ZA200002338B (en) 2001-11-12

Similar Documents

Publication Publication Date Title
IL164599A0 (en) Combination therapy for the treatment of cancer
AU2002350235A1 (en) Combination bacteriolytic therapy for the treatment of tumors
IL158329A0 (en) Antiangiogenic combination therapy for the treatment of cancer
EP1077704A4 (fr) Therapie combinee destinee au traitement de la depression
IL159887A0 (en) Combination therapy for the treatment of cancer
KR100510795B1 (en) Compositions and Methods for the Treatment of Tumor
IL146697A0 (en) SELECTIVE iGluR5 RECEPTOR FOR THE TREATMENT OF MIGRAINE
IL136960A0 (en) Combination therapy for the treatment of migraine
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
ZA200110436B (en) Therapeutic use of melatonin.
AU2001285156A1 (en) Combination therapy for the treatment of migraine
IL136962A0 (en) Combination therapy for the treatment of migraine
IL136025A0 (en) Combination therapy for the treatment of migraine
IL136024A0 (en) Combination therapy for the treatment of migraine
HUP0100365A3 (en) Combination therapy for the treatment of aids
GB2363604B (en) S-nitrosothiols as agents for the treatment of circulatory dsyfunctions
SI1451177T1 (sl) Substituirani 2-pirolidin-2-il-1H-indolni derivati za zdravljenje migrene
GB9904252D0 (en) Composition for the treatment of pain
GB9807938D0 (en) Combination therapy for the treatment of AIDS
GB9819590D0 (en) Combination therapy for the treatment of aids
KR100511819B1 (en) Compositions and Methods for the Treatment of Tumor
GB9901505D0 (en) Therapeutic treatment
GB9924980D0 (en) Therapeutic treatment
ZA9810306B (en) Combination therapy for the treatment of aids
KR100512820B1 (en) Compositions and Methods for the Treatment of Tumor